Other ·Insufficient evidence ·Reviewed May 2026
Cocaine is not supported by NutriStack. Safety information only.
The bottom line
Evidence rating insufficient. 15 sources indexed (1991–2025), with 8 interaction records on file.
Dosing protocol
Highly addictive; cardiovascular and overdose risk.
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Not recommended / controlled substance.
No effective supplement dose exists. Cost is intentionally not modeled for this illegal non-medical substance. Updated 2026-05-28.
How much you'd eat to match a supplemental dose.
Cocaine is a controlled stimulant drug, not a nutrient or diet-replaceable supplement.
What to test, the optimal window inside the conventional range, and how long a response takes.
Cocaine is metabolized primarily to benzoylecgonine, which has a longer half-life than cocaine itself and is the standard urine marker.1,2
Cocaine carries acute cardiovascular and overdose risk. Hair testing extends detection to 90 days.
Butyrylcholinesterase has genetic variants that affect enzyme activity and is relevant to cocaine hydrolysis biology (PMID 25448037).
Recommendation: BCHE status is not a harm-reduction substitute. Cocaine exposure carries serious cardiovascular and neurologic risk regardless of genotype.
Combining cocaine with alcohol produces cocaethylene in the liver, a longer-lasting and more cardiotoxic compound that sharply increases the risk of heart attack, arrhythmia, and sudden death.
Recommendation: Do not combine. This is a dangerous combination associated with sudden cardiac death. If experiencing chest pain, severe agitation, or breathing difficulty, seek emergency medical care immediately.
Using cocaine and nicotine together compounds sympathetic stimulation, raising heart rate, blood pressure, and coronary vasoconstriction, which increases cardiovascular strain and the risk of cardiac events.
Recommendation: Do not combine. The two together place additive strain on the heart and coronary arteries. Seek medical advice for stimulant use and stop if chest pain or palpitations occur.
Cocaine and amphetamine/dextroamphetamine are both sympathomimetic stimulants. Using them together can intensify tachycardia, hypertension, coronary vasospasm, overheating, anxiety, and arrhythmia risk. The danger is higher with high stimulant doses, dehydration, strenuous activity, or any history of heart disease, high blood pressure, panic attacks, or stimulant use disorder.
Recommendation: Do not use cocaine while taking amphetamine/dextroamphetamine. If cocaine exposure occurs, do not take extra stimulant doses and avoid exercise or overheating. Seek emergency care for chest pain, fainting, severe headache, severe agitation, shortness of breath, or a racing or irregular heartbeat.
Lisdexamfetamine is converted to dextroamphetamine and produces stimulant cardiovascular effects that can overlap with cocaine. Combining them can increase heart rate, blood pressure, myocardial oxygen demand, anxiety, insomnia, overheating, and arrhythmia risk. Controlled cocaine-use studies used careful screening and monitoring, so they should not be treated as proof that real-world co-use is safe.
Recommendation: Do not use cocaine while taking lisdexamfetamine. Do not raise or repeat either substance to overcome a blunted effect. Seek emergency care for chest pain, severe headache, fainting, shortness of breath, confusion, severe agitation, or an irregular heartbeat.
Methylphenidate and cocaine both act as stimulant monoamine transporter blockers. A small controlled study did not find clinically significant physiologic toxicity at the tested doses, but cocaine still has well-established risks of acute hypertension, coronary spasm, arrhythmias, and myocardial infarction. Real-world cocaine dose, purity, route, and redosing make this combination unsafe.
Recommendation: Do not use cocaine while taking methylphenidate. Do not take extra methylphenidate to counter cocaine withdrawal or fatigue. Seek emergency care for chest pain, severe headache, fainting, severe anxiety or agitation, shortness of breath, or a racing or irregular heartbeat.
Cocaine and albuterol can both increase adrenergic cardiovascular stress. Cocaine can cause tachycardia, hypertension, coronary vasospasm, myocardial ischemia, and arrhythmias, while albuterol can add tachycardia, tremor, hypokalemia, and electrophysiologic changes at higher exposure. Smoked cocaine can also provoke bronchospasm, creating a dangerous cycle of airway symptoms and escalating rescue-inhaler use.
Recommendation: Do not use cocaine while using albuterol. If cocaine exposure occurs, do not keep repeating albuterol for chest tightness without medical assessment, because symptoms may reflect bronchospasm, ischemia, panic, or arrhythmia. Seek emergency care for chest pain, severe shortness of breath, fainting, severe agitation, or a fast or irregular heartbeat.
Atomoxetine and cocaine both increase noradrenergic cardiovascular stress. A monitored inpatient study in cocaine-experienced participants found atomoxetine plus intravenous cocaine was tolerated at tested doses, but cocaine still produced heart-rate and blood-pressure responses; a later abstinent-user study found atomoxetine increased heart rate and systolic blood pressure versus placebo. Real-world cocaine dose, route, adulterants, and redosing make co-use unsafe outside monitored research conditions.
Recommendation: Avoid cocaine while taking atomoxetine. Do not take extra atomoxetine to offset cocaine crash, fatigue, or attention problems. Seek emergency care for chest pain, severe headache, fainting, severe agitation, shortness of breath, or a fast or irregular heartbeat.
Pseudoephedrine and cocaine are both sympathomimetic stimulants, so combined use can sharply increase blood pressure, heart rate, vasoconstriction, and myocardial oxygen demand. Cocaine is linked to acute hypertension, coronary spasm, arrhythmias, myocardial infarction, and sudden cardiovascular events. Adding pseudoephedrine can further intensify adrenergic stress.
Recommendation: Do not use pseudoephedrine if you have used cocaine or may use cocaine soon. Seek urgent care for chest pain, severe headache, fainting, severe agitation, or a very fast or irregular heartbeat. Use non-stimulant congestion treatments instead.
Numbered references. Citations throughout the page link here.
Brobbin E, Lowry N, Cella M et al.. Cocaine Cues Used in Experimental Research: A Systematic Review. Brain sciences. 2025
Biso L, Lebosi M, Bonaso M et al.. Methylphenidate for the Treatment of Cocaine Use Disorder: A Systematic Review and Meta-analysis. Journal of addiction medicine. 2025
Kaushik S, Ahmad F, Choudhary S et al.. Critical appraisal and systematic review of genes linked with cocaine addiction, depression and anxiety. Neuroscience and biobehavioral reviews. 2023
Owe-Larsson M, Pawłasek J, Piecha T et al.. The Role of Cocaine- and Amphetamine-Regulated Transcript (CART) in Cancer: A Systematic Review. International journal of molecular sciences. 2023
Torres-Castaño A, Rivero-Santana A, Perestelo-Pérez L et al.. Transcranial Magnetic Stimulation for the Treatment of Cocaine Addiction: A Systematic Review. Journal of clinical medicine. 2021
Arenas DJ, Beltran S, Zhou S et al.. Cocaine, cardiomyopathy, and heart failure: a systematic review and meta-analysis. Scientific reports. 2020
Pham D, Addison D, Kayani W et al.. Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis. Emergency medicine journal : EMJ. 2018
Nocito Echevarria MA, Andrade Reis T, Ruffo Capatti G et al.. N-acetylcysteine for treating cocaine addiction - A systematic review. Psychiatry research. 2017
Sangroula D, Motiwala F, Wagle B et al.. Modafinil Treatment of Cocaine Dependence: A Systematic Review and Meta-Analysis. Substance use & misuse. 2017
Levin FR, Lehman AF. Meta-analysis of desipramine as an adjunct in the treatment of cocaine addiction. Journal of clinical psychopharmacology. 1991
Elkashef A, Brašić JR, Cantelina LR Jr et al.. A cholecystokinin B receptor antagonist and cocaine interaction, phase I study. CNS neuroscience & therapeutics. 2019
Human study showed intranasal cocaine markedly increased sympathetic nerve activity, blood pressure, and heart rate via a central mechanism.
Review summarizes links to hypertension, arrhythmia, myocardial infarction, and coronary disease, especially in people with higher baseline cardiac risk.
Brunt TM, van den Berg J, Pennings E et al.. Adverse effects of levamisole in cocaine users: a review and risk assessment. Archives of toxicology. 2017
Review argues chronic cocaine hijacks reward-related dopamine plasticity and contributes to persistent addiction pathology.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack